Efficacy [qlco]
Safety [hcpp]
Women [popg]
Primary [qlco]
Hypercholesterolaemia [dsyn]
Women [popg]
Primary hypercholesterolaemia [dsyn]
Often [tmco]
considered [idcn]
Lipid-lowering therapy [topp]
Drug [phsu]
Late [tmco]
Age [orga]
Men [popg]
Prevention [topp]
Cardiovascular morbidity [dsyn]
Women [popg]
To [qlco]
Receive [qlco]
Same [qlco]
Benefits [qnco]
Lipid [lipd]
lowering [spco]
treatment [ftcn]
Men [popg]
Interest [menp]
Evaluate [ftcn]
Efficacy [qlco]
Safety [hcpp]
TOLERABILITY [resa]
New [tmco]
Lipid lowering agent [phsu]
fluvastatin [orch, phsu]
Women [popg]
retrospective [resa]
Analysis [lbpr]
Make [ftcn]
Data [idcn]
Controlled Clinical Trial [inpr]
Patients [podg]
treated [topp]
fluvastatin [orch, phsu]
Daily Dose [qnco]
Equal [qlco]
Patients [podg]
Received [qlco]
placebo [topp]
fluvastatin [orch, phsu]
treated [topp]
Patients [podg]
Patients [podg]
placebo [topp]
Women [popg]
Group [idcn]
Patients [podg]
treated [topp]
fluvastatin [orch, phsu]
Patients [podg]
Receive [qlco]
placebo [topp]
Age [orga]
Effect [qlco]
Low density lipoprotein [aapp, bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
More [ftcn]
Favorable [qlco]
Women [popg]
Men [popg]
Women [popg]
Change [ftcn]
baseline [bodm]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Men [popg]
Equivalent [qlco]
baseline [bodm]
Change [ftcn]
baseline [bodm]
Highly significant [qlco]
P NOS [aapp, imft]
fluvastatin [orch, phsu]
Lower triglycerides [fndg]
Similar [qlco]
Extent [spco]
Women [popg]
Men [popg]
More [ftcn]
Women [popg]
Men [popg]
experience [menp]
confirmed [qlco]
Increase [ftcn]
Aspartate Aminotransferase [aapp, enzy]
Alanine Aminotransferase [aapp, enzy]
Receive [qlco]
fluvastatin [orch, phsu]
increases [ftcn]
Observed [ftcn]
Women [popg]
Men [popg]
Women [popg]
Men [popg]
placebo [topp]
treated [topp]
Patients [podg]
Increase [ftcn]
Observed [ftcn]
Gender [orga]
Increase [ftcn]
Note [clna]
One [qnco]
male patient [orga]
One [qnco]
female patient [orga]
increases [ftcn]
Creatine Phosphokinase [aapp, enzy]
times [tmco]
Upper [spco]
limit [ftcn]
Normal [qlco]
Observed [ftcn]
Women [popg]
TOLERABILITY [resa]
fluvastatin [orch, phsu]
Assessed [acty]
Analysis [lbpr]
adverse events [fndg]
Not [ftcn]
Gender [orga]
Conclusion [idcn]
Analysis [lbpr]
Efficacy [qlco]
Safety [hcpp]
fluvastatin [orch, phsu]
Suggest [idcn]
effective [qlco]
Well [qlco]
Gender [orga]
Observed [ftcn]
Enhanced [acty]
Efficacy [qlco]
Women [popg]
Further [spco]
Evaluated [ftcn]
Data [idcn]
Prospective Studies [resa]
female patients [orga]
